This Article Full Text Full Text (PDF) All Versions of this Article: 49/3/625    most recent 01.HYP.0000254833.85106.4dv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Padia, S. H. Articles by Carey, R. M. Search for Related Content PubMed PubMed Citation Articles by Padia, S. H. Articles by Carey, R. M. Related Collections ACE/Angiotension receptors Hypertension - basic studies

(Hypertension. 2007;49:625.)
© 2007 American Heart Association, Inc.

Original Articles, Part 2

Intrarenal Aminopeptidase N Inhibition Augments Natriuretic Responses to Angiotensin III in Angiotensin Type 1 Receptor–Blocked Rats

Shetal H. Padia; Brandon A. Kemp; Nancy L. Howell; Helmy M. Siragy; Marie-Claude Fournie-Zaluski; Bernard P. Roques; Robert M. Carey

From the Division of Endocrinology and Metabolism (S.H.P., B.A.K., N.L.H., H.M.S., R.M.C.), Department of Internal Medicine, University of Virginia Health System, Charlottesville; and Institut National de la Sante et de la Recherche Medicale U36 (M.-C.F.-Z., B.P.R.), UFR des Sciences Pharmaceutiques et Biologigues, Universite Rene Descartes, Paris, France.

Correspondence to Robert M. Carey, PO Box 801414, University of Virginia Health System, Charlottesville, VA 22908-1414. E-mail rmc4c{at}virginia.edu

The renal angiotensin angiotensin type 2 receptor has been shown to mediate natriuresis, and angiotensin III, not angiotensin II, may be the preferential angiotensin type 2 receptor activator of this response. Angiotensin III is metabolized to angiotensin IV by aminopeptidase N. The present study hypothesizes that inhibition of aminopeptidase N will augment natriuretic responses to intrarenal angiotensin III in angiotension type 1 receptor–blocked rats. Rats received systemic candesartan for 24 hours before the experiment. After a 1-hour control, cumulative renal interstitial infusion of angiotensin III at 3.5, 7, 14, and 28 nmol/kg per minute (each dose for 30 minutes) or angiotensin III combined with aminopeptidase N inhibitor PC-18 was administered into 1 kidney. The contralateral control kidney received renal interstitial infusion of vehicle. In kidneys infused with angiotensin III alone, renal sodium excretion rate increased from 0.05±0.01 µmol/min in stepwise fashion to 0.11±0.01 µmol/min at 28 nmol/kg per minute of angiotensin III (overall ANOVA F=3.68; P<0.01). In angiotensin III combined with PC-18, the renal sodium excretion rate increased from 0.05±0.01 to 0.32±0.08 µmol/min at 28 nmol/kg per minute of angiotensin III (overall ANOVA F=6.2; P<0.001). The addition of intrarenal PD-123319, an angiotensin type 2 receptor antagonist, to renal interstitial angiotensin III plus PC-18 inhibited the natriuretic response. Mean arterial blood pressure and renal sodium excretion rate from control kidneys were unchanged by angiotensin III ± PC-18 + PD-123319. Angiotensin III plus PC-18 induced a greater natriuretic response than Ang III alone (overall ANOVA F=16.9; P=0.0001). Aminopeptidase N inhibition augmented the natriuretic response to angiotensin III, suggesting that angiotensin III is a major agonist of angiotensin type 2 receptor–induced natriuresis.

Key Words: angiotensin • sodium • natriuresis • angiotensin III • AT₂ receptor • AT₁ receptor

This article has been cited by other articles:

				S. H. Padia, B. A. Kemp, N. L. Howell, M.-C. Fournie-Zaluski, B. P. Roques, and R. M. Carey Conversion of Renal Angiotensin II to Angiotensin III Is Critical for AT2 Receptor-Mediated Natriuresis In Rats Hypertension, February 1, 2008; 51(2): 460 - 465. [Abstract] [Full Text] [PDF]